Advertisement
(Photo: http://www.newscom.com/cgi-bin/prnh/20090309/NE81090 )
Michael comes to CXHC with more than 20 years of pharmaceutical clinical and commercial development experience. Michael began his career at Bristol-Myers Squibb Company in the role of Clinical Research Manager and Marketing Communications Manager. Afterward, he served in senior management roles with several healthcare communications companies and contract research organizations. Most recently, Michael served as Executive Director of the Flagship Global Health Foundation, an organization dedicated to clinical research and education with offices in New York, and Beijing, China.
Advertisement
Susan Stein, Chief Executive Officer and founder of CXHC states: "Michael's expertise will further support the overall growth of CXHC, helping to maintain its continued commitment to quality, service, education, and creativity in program execution; He brings many years of successful corporate and entrepreneurial experience to our organization. We welcome his vision and solutions-oriented approach."
Grounded in science and inspired by passion, CXHC is a group of independent but complementary healthcare communications companies dedicated to developing high-quality scientific programs. Its mission is to educate, motivate, and inspire healthcare professionals across all therapeutic areas to help improve patient care. CXHC is committed to the knowledge that innovative solutions, quality execution, business integrity, and results are the keys to forging strong and enduring business relationships. This philosophy guides the company's 3 main operating units: Clinical CONNEXION (CCX), a full-service healthcare communications company; Publication CONNEXION (PCX), a strategic publications planning company.
SOURCE CONNEXION Healthcare
